Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Albert Cha currently holds 18,000 shares of KalVista Pharmaceuticals, Inc. (KALV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Albert Cha has been a net buyer of KALV stock. They have purchased $35.0M and sold $189.0K worth of shares.
Albert Cha's most recent insider trade was on Sep 11, 2023, when they sold 12,000 shares at $7.88 per share.
Albert Cha serves as Executive at KalVista Pharmaceuticals, Inc. (KALV). They have executed 23 insider transactions totaling $35.2M over their tenure at the company.
Albert Cha holds the position of Executive at KalVista Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Albert Cha has shown a buying trading pattern, with $35.0M in total purchases and $189.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Albert Cha was on Sep 10, 2018, when they purchased $18.0M worth of KALV shares. This transaction involved 1,058,824 shares at $17.00 per share.
Albert Cha currently owns 18,000 shares of KalVista Pharmaceuticals, Inc. (KALV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Albert Cha's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Albert Cha has 23 Form 4 filings on record as an insider at KalVista Pharmaceuticals, Inc..
Set alerts for Albert Cha and 40,000+ other insiders.